Definium Therapeutics Balance Sheet
NASDAQ: DFTXHealth Care Medicinal Chemicals and Botanical Products USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Definium Therapeutics financial position
At the end of fiscal 2025, Definium Therapeutics reported total assets of $440.1 million, up 45.7% from a year earlier against total liabilities of $107.8 million. Shareholders' equity stood at $332.3 million, or 75.5% of assets. The company held $257.8 million in cash and equivalents against $40.6 million of debt, a net cash position of $217.3 million.
The current ratio (current assets divided by current liabilities) was 6.29, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.12.
Summary generated from market data by MetaCap's automated system. Methodology
Definium Therapeutics balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 257.84M | 273.74M | 99.70M | 142.14M | 133.54M | 80.09M |
| Short-Term Investments | 153.76M | 0 | — | — | — | — |
| Total Current Assets | 419.32M | 281.62M | 103.87M | 146.06M | 137.22M | 81.52M |
| Goodwill | 19.92M | 19.92M | 19.92M | 19.92M | 19.92M | 0 |
| Intangible Assets | — | 0 | 527.00K | 3.69M | 6.87M | — |
| Long-Term Investments | — | 0 | — | — | — | — |
| Total Assets | 440.10M | 302.15M | 124.54M | 169.99M | 164.00M | 81.52M |
| Accounts Payable | 5.35M | 2.01M | 4.14M | 2.11M | 4.18M | 2.02M |
| Total Current Liabilities | 66.70M | 38.85M | 32.25M | 17.89M | 10.41M | 3.01M |
| Long-Term Debt | 40.58M | 21.85M | 14.13M | — | — | — |
| Total Liabilities | 107.77M | 60.70M | 46.41M | 19.08M | 12.34M | 5.65M |
| Shareholders' Equity | 332.33M | 241.45M | 78.13M | 150.92M | 151.66M | 75.87M |
| Retained Earnings | -582.67M | -398.88M | -290.20M | -194.47M | -137.67M | -44.64M |
| Total Debt | 40.58M | 21.85M | 14.13M | — | — | — |
| Net Cash (Debt) | 371.01M | 251.89M | 85.58M | 142.14M | 133.54M | 80.09M |
| Shares Outstanding | 98.78M | 75.10M | 41.10M | 37.98M | 28.13M | — |
This table shows 6 annual periods of Definium Therapeutics's balance sheet, from FY 2025 back to FY 2020, across 16 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow DFTX's reporting calendar. What is a balance sheet?